Source: Eur Respir J 2011; 37: 1386-1391
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ruiter G., Lankhorst S., Boonstra A., Postmus P.E., Zweegman S., Westerhof N., van der Laarse W.J., Vonk-Noordegraaf A.. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J 2011; 37: 1386-1391

Member's Comments

No comment yet.

Related content which might interest you: Iron deficiency in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 High prevalence of iron deficiency in idiopathic pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Iron deficiency in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target Source: Eur Respir J 2011; 38: 1453-1460 Year: 2011 Exercise limitation in idiopathic pulmonary arterial hypertension (IPAH): there‘s more to it than just the pulmonary circulation Source: Eur Respir J 2005; 26: Suppl. 49, 560s Year: 2005 Dysregulation of iron homeostasis in Eisenmenger syndrome; comparison to idiopathic pulmonary arterial hypertension and healthy controls Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012 Iron deficiency in pulmonary arterial hypertension: A matter of definition! Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 BMPR2 mutations and iron metabolism in pulmonary arterial hypertension patients Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Transferrin in patients with idiopathic pulmonary arterial hypertension: correlation with exercise capacity Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Exercise-induced immune response in patients with idiopathic pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights Year: 2015 Contrasting cardiovascular responses to exercise in mitochondrial myopathy and pulmonary arterial hypertension Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease Year: 2016 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children Source: Eur Respir J 2011; 37: 70-77 Year: 2011 Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene Source: Eur Respir J 2001; 17: 1065-1069 Year: 2001 More on idiopathic pulmonary arterial hypertension with a low diffusing capacity Source: Eur Respir J, 50 (2) 1700354; 10.1183/13993003.00354-2017 Year: 2017 Pulmonary hypertension in patients with COPD Source: Eur Respir Mon 2012; 57: 138-147 Year: 2012 Pulmonary hypertension in sickle cell disease Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease Year: 2007 Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia Source: International Congress 2017 – PAH and CTEPH Year: 2017